ATTENTION: The software behind KU ScholarWorks is being upgraded to a new version. Starting July 15th, users will not be able to log in to the system, add items, nor make any changes until the new version is in place at the end of July. Searching for articles and opening files will continue to work while the system is being updated.
If you have any questions, please contact Marianne Reed at mreed@ku.edu .
Plasma methionine sulfoxide in persons with familial Alzheimer’s disease mutations
dc.contributor.author | Ringman, John M. | |
dc.contributor.author | Fithian, Andrew T. | |
dc.contributor.author | Gylys, Karen | |
dc.contributor.author | Cummings, Jeffrey L. | |
dc.contributor.author | Coppola, Giovanni | |
dc.contributor.author | Elashoff, David | |
dc.contributor.author | Pratico, Domenico | |
dc.contributor.author | Moskovitz, Jackob | |
dc.contributor.author | Bitan, Gal | |
dc.date.accessioned | 2017-06-09T16:28:59Z | |
dc.date.available | 2017-06-09T16:28:59Z | |
dc.date.issued | 2012 | |
dc.identifier.citation | Ringman, J. M., Fithian, A. T., Gylys, K., Cummings, J. L., Coppola, G., Elashoff, D., … Bitan, G. (2012). Plasma methionine sulfoxide in persons with familial Alzheimer’s disease mutations. Dementia and Geriatric Cognitive Disorders, 33(4), 219–225. http://doi.org/10.1159/000338546 | en_US |
dc.identifier.uri | http://hdl.handle.net/1808/24461 | |
dc.description | The final, published version of this article is available at http://www.karger.com/?doi=10.1159/000338546. | en_US |
dc.description.abstract | BACKGROUND: Convergent evidence suggests that oxidative stress plays a central role in the pathology of Alzheimer’s disease (AD). We asked if consequently, oxidation of methionine residues to methionine sulfoxide (MetO) increased in plasma proteins of persons carrying familial AD (FAD) mutations. METHODS: Plasma was collected from 31 persons from families harboring PSEN1 or APP mutations. Using Western blot analysis with a novel anti-MetO polyclonal antibody, MetO levels were measured and compared between FAD mutation carriers (MCs) and non-mutation carrying (NCs) kin. RESULTS: A MetO-positive 120 kDa gel band distinguished FAD MCs and NCs (mean 11.4 ± 2.8 vs. 4.0 ± 3.1, p = 0.02). In a subset of subjects for whom both measurements were available, MetO levels correlated well with plasma F2-isoprostane (r = 0.81, p < 0.001) and superoxide dismutase 1 (r = 0.52, p = 0.004) levels. CONCLUSIONS: Our data provide evidence for elevated MetO levels in persons carrying FAD mutations that correlate with other indices of oxidative stress and suggest that plasma oxidative stress markers may be useful for diagnosis of AD. | en_US |
dc.publisher | Karger Publishers | en_US |
dc.subject | Oxidative stress | en_US |
dc.subject | Isoprostanes | en_US |
dc.subject | Plasma | en_US |
dc.subject | Superoxide dismutase | en_US |
dc.subject | Presenilin-1 | en_US |
dc.subject | Amyloid β-protein precursor | en_US |
dc.title | Plasma methionine sulfoxide in persons with familial Alzheimer’s disease mutations | en_US |
dc.type | Article | en_US |
kusw.kuauthor | Moskovitz, Jackob | |
kusw.kudepartment | Pharmacy | en_US |
dc.identifier.doi | 10.1159/000338546 | en_US |
kusw.oaversion | Scholarly/refereed, author accepted manuscript | en_US |
kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
dc.identifier.pmid | PMC3568669 | en_US |
dc.rights.accessrights | openAccess |
Files in this item
This item appears in the following Collection(s)
-
Pharmacy Scholarly Works [299]